Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

fiercebiotech.com

FierceBiotech

Get the latest updates from FierceBiotech directly as they happen.

Follow now 337 followers

Latest posts

Last updated about 2 hours ago

Vincetage sees 12.4% weight loss for oral GLP-1, will chase Lilly to Chinese regulators

about 2 hours ago

Vincentage Pharma’s oral GLP-1 agonist has been tied to mean weight loss...

BioMarin’s $270M Inozyme bet looks in trouble after rare disease drug misses key ph. 3 goal

about 4 hours ago

BioMarin’s $270 million bet on Inozyme’s enzyme replacement therapy looks in trouble...

After rare disease flop, cash-strapped Quince finds salvation in reverse merger

about 4 hours ago

After launching a hunt for strategic alternatives in January following a phase...

Nominations now open for Fierce Biotech's 2026 Fierce 15

about 5 hours ago

It's time to kick off our annual hunt for the latest crop...

Vincentage sees 12.4% weight loss for oral GLP-1, will chase Lilly to Chinese regulators

about 5 hours ago

Vincentage Pharma’s oral GLP-1 agonist has been tied to mean weight loss...

Regeneron pens $2.3B pact with Parabilis to develop new type of ADC-like therapy

about 6 hours ago

Regeneron has ponied up $125 million in cash and an equity investment...

Boston Scientific funnels $1.5B into MiRus, with option to buy TAVR system

about 6 hours ago

Acquisitive Boston Scientific is making deals again with a major investment play...

Ipsen unveils data for Botox rival that drove long-acting anti-wrinkle jab into phase 3

about 9 hours ago

Ipsen has shared phase 2 data on its long-acting neurotoxin, reporting an...

Analysts ‘shaking heads’ after Regeneron melanoma drug fails to beat Keytruda in phase 3 trial

about 10 hours ago

A phase 3 trial of Regeneron’s LAG-3 inhibitor has missed its primary...

Ardent Health taps Fujifilm’s AI-enabled patient imaging platform

about 12 hours ago

Fujifilm Healthcare Americas Corp. has signed a deal with Ardent Health to...

Executing biomarker-driven oncology trials

3 days ago

Why biomarker-driven oncology trials require new thinking across patient recruitment, assay development...

Transforming neurodegenerative disease treatment

3 days ago

Discover how Cognition Therapeutics is redefining hope for Alzheimer’s and Dementia with...